Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
176.11
-4.77 (-2.64%)
Sep 15, 2025, 4:00 PM EDT - Market closed
Molina Healthcare Stock Forecast
Stock Price Forecast
The 11 analysts that cover Molina Healthcare stock have a consensus rating of "Hold" and an average price target of $225.18, which forecasts a 27.86% increase in the stock price over the next year. The lowest target is $179 and the highest is $345.
Price Target: $225.18 (+27.86%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 5 | 5 | 6 | 3 | 3 | 3 |
| Hold | 9 | 9 | 9 | 10 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 14 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $284 → $220 | Buy | Maintains | $284 → $220 | +24.92% | Sep 5, 2025 |
| Barclays | Barclays | Hold Maintains $186 → $185 | Hold | Maintains | $186 → $185 | +5.05% | Sep 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $210 | Hold | Reiterates | $210 | +19.24% | Aug 26, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $216 → $198 | Buy | Maintains | $216 → $198 | +12.43% | Aug 15, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $272 → $184 | Hold | Maintains | $272 → $184 | +4.48% | Jul 29, 2025 |
Financial Forecast
Revenue This Year
44.87B
from 39.16B
Increased by 14.57%
Revenue Next Year
47.91B
from 44.87B
Increased by 6.77%
EPS This Year
19.23
from 20.42
Decreased by -5.82%
EPS Next Year
20.65
from 19.23
Increased by 7.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.3B | 51.0B | |||
| Avg | 44.9B | 47.9B | |||
| Low | 43.1B | 45.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.8% | 13.6% | |||
| Avg | 14.6% | 6.8% | |||
| Low | 10.0% | 0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.35 | 32.55 | |||
| Avg | 19.23 | 20.65 | |||
| Low | 16.08 | 16.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.4% | 69.3% | |||
| Avg | -5.8% | 7.4% | |||
| Low | -21.2% | -16.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.